Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • cas 63074-08-8 terazosin hydrochloride

Oct . 07, 2024 02:08 Back to list

cas 63074-08-8 terazosin hydrochloride



Terazosin Hydrochloride An Overview


Terazosin hydrochloride, identified by the CAS number 63074-08-8, is a medication primarily used to treat conditions such as benign prostatic hyperplasia (BPH) and hypertension. It falls under the category of alpha-1 adrenergic antagonists, a class of drugs that help relax certain muscles and improve blood flow.


Mechanism of Action


Terazosin works by inhibiting the action of norepinephrine on alpha-1 adrenergic receptors, which are predominantly found in the smooth muscles of the blood vessels and the prostate gland. When these receptors are blocked, the smooth muscle relaxation leads to vasodilation, resulting in decreased blood pressure and improved urinary flow. This property makes terazosin particularly effective for men who experience urinary symptoms due to an enlarged prostate, as it can alleviate issues like urinary hesitancy and frequency.


Indications


The primary indications for terazosin include

1. Benign Prostatic Hyperplasia (BPH) As men age, the prostate gland can enlarge, leading to various urinary symptoms. Terazosin helps relieve these symptoms by relaxing the prostate and bladder neck muscles. 2. Hypertension Although not the first-line treatment for high blood pressure, terazosin can be prescribed alone or in combination with other antihypertensive agents. Its ability to reduce vascular resistance makes it a suitable option for certain patients.


Dosage and Administration


cas 63074-08-8 terazosin hydrochloride

cas 63074-08-8 terazosin hydrochloride

Terazosin is usually taken orally in the form of capsules. The dosage varies depending on the condition being treated. For BPH, the typical initial dose is 1 mg taken at bedtime, which may be gradually increased based on the patient's response and tolerance. For hypertension, the starting dose may also be 1 mg, but can be adjusted as necessary. It is important to follow a healthcare provider’s instructions regarding dosage to minimize side effects and ensure efficacy.


Side Effects


Like any medication, terazosin can cause side effects. Common side effects include dizziness, headache, fatigue, and nasal congestion. A notable concern is the risk of orthostatic hypotension, especially after the first dose. This occurs when a person stands up suddenly, leading to a drop in blood pressure and potential fainting. For this reason, it is advisable for patients to rise slowly from sitting or lying positions after taking the medication.


Patients are also advised to contact their healthcare provider if they experience severe side effects such as persistent cough, swelling of the face or limbs, or signs of an allergic reaction. Regular follow-up appointments are essential to monitor the effectiveness of the treatment and make necessary adjustments.


Contraindications and Precautions


Terazosin is contraindicated in patients with a known hypersensitivity to the drug or any component of its formulation. Caution should be exercised in patients with a history of prostate cancer, liver issues, or those taking other medications that lower blood pressure, as this can increase the risk of adverse effects.


Conclusion


Terazosin hydrochloride is a valuable medication for managing symptoms related to benign prostatic hyperplasia and hypertension. Its ability to relax smooth muscles in the urinary tract and blood vessels makes it effective for improving patients' quality of life. However, understanding potential side effects, contraindications, and the importance of medical supervision is crucial for anyone considering terazosin as part of their treatment plan. Always consult healthcare professionals for tailored advice and recommendations regarding medication use.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish